Illumina Inc. agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act by selling genomic sequencing systems with #cybersecurity vulnerabilities to federal agencies. Read more: https://t.co/KK2TeKYMbY pic.twitter.com/2r7FFb9Y6N

— OIG at HHS (@OIGatHHS) August 1, 2025